Vertex Pharmaceuticals Incorporated (VPI) is focused on developing and commercializing therapies for the treatment of cystic fibrosis, or CF, and advancing its research and development programs in other diseases. Company’s key products include ORKAMBI (lumacaftor in combination with ivacaftor), KALYDECO (ivacaftor) and SYMDEKO (tezacaftor in combination with ivacaftor).
This is a single user license,allowing one specific user access to the product.
This is a multi-users license,allowing up to five users access to the product.
This includes PDF report, Excel pivot data, PowerPoint Slides & Print Option.This will allow all employees within your organization access to the product.
Subscribe to our mailing list and get interesting stuff and updates to your mail box.